MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 76 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $112,046 | – | 15,893 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,692,298 | $43,461,484 | 2.90% |
| Aisling Capital Management LP | 1,472,331 | $8,318,670 | 2.48% |
| Alphabet Inc. | 1,464,015 | $8,271,684 | 0.38% |
| Avoro Capital Advisors LLC | 4,535,000 | $25,622,750 | 0.35% |
| Baker Brothers Advisors | 4,916,095 | $27,775,937 | 0.32% |
| Casdin Capital, LLC | 510,882 | $2,886,483 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 48,511 | $274,087 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $157,319 | 0.03% |
| Caption Management, LLC | 224,300 | $1,267,295 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 44,247 | $249,996 | 0.01% |